Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 15th:
The Chemours Company (NYSE:CC) CC: This company that provides performance chemicals carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.
Chemours has a PEG ratio of 0.22 compared with 0.62 for the industry. The company possesses a Growth Score of A.
Laboratory Corporation of America (NYSE:LH) Holdings LH: This independent clinical laboratory company carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.8% over the last 60 days.
Laboratory Corp has a PEG ratio of 1.02, compared with 2.17 for the industry. The company possesses a Growth Score of B.
Heritage-Crystal Clean (NASDAQ:HCCI), Inc HCCI: This company that provides parts cleaning, hazardous and non-hazardous waste, and used oil collection services carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.3% over the last 60 days.
Heritage-Crystal Clean has a PEG ratio of 0.84, compared with 2.48 for the industry. The company possesses a Growth Score of B.
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Laboratory Corporation of America Holdings (LH): Free Stock Analysis Report
HeritageCrystal Clean, Inc. (HCCI): Free Stock Analysis Report
The Chemours Company (CC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research